Martin A. Makary and Vinay Prasad write that “rapid or instant reviews” could be possible at the FDA.

Our latest news roundup reports on dysfunction observed in edited blood stem cells, and RFK Jr’s support for experimental treatments.

There has been no new TB vaccine for over 100 years, but a candidate in phase III has just finished enrolling the target of 20,000 participants.

Stanford University researchers explore how zinc fingers can enhance gene therapy.

All 17 members removed from advisory panel, with RFJ Jr claiming it is “plagued with conflict of interest.”

The challenges of developing optimized biologics formulations are well known, but the good news is that the industry continues to develop solutions.

We explore how AI-based tools are making a mark in formulation by improving solubility.

A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.